1. Home
  2. AKRO vs WU Comparison

AKRO vs WU Comparison

Compare AKRO & WU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AKRO
  • WU
  • Stock Information
  • Founded
  • AKRO 2017
  • WU 1851
  • Country
  • AKRO United States
  • WU United States
  • Employees
  • AKRO N/A
  • WU N/A
  • Industry
  • AKRO Biotechnology: Pharmaceutical Preparations
  • WU Business Services
  • Sector
  • AKRO Health Care
  • WU Consumer Discretionary
  • Exchange
  • AKRO Nasdaq
  • WU Nasdaq
  • Market Cap
  • AKRO 2.8B
  • WU 3.3B
  • IPO Year
  • AKRO 2019
  • WU 2006
  • Fundamental
  • Price
  • AKRO $39.85
  • WU $9.76
  • Analyst Decision
  • AKRO Strong Buy
  • WU Hold
  • Analyst Count
  • AKRO 9
  • WU 10
  • Target Price
  • AKRO $76.29
  • WU $11.19
  • AVG Volume (30 Days)
  • AKRO 1.1M
  • WU 7.2M
  • Earning Date
  • AKRO 05-16-2025
  • WU 04-23-2025
  • Dividend Yield
  • AKRO N/A
  • WU 9.64%
  • EPS Growth
  • AKRO N/A
  • WU 59.38
  • EPS
  • AKRO N/A
  • WU 2.70
  • Revenue
  • AKRO N/A
  • WU $4,144,200,000.00
  • Revenue This Year
  • AKRO N/A
  • WU $1.48
  • Revenue Next Year
  • AKRO N/A
  • WU $1.69
  • P/E Ratio
  • AKRO N/A
  • WU $3.62
  • Revenue Growth
  • AKRO N/A
  • WU N/A
  • 52 Week Low
  • AKRO $17.86
  • WU $9.00
  • 52 Week High
  • AKRO $58.40
  • WU $13.49
  • Technical
  • Relative Strength Index (RSI)
  • AKRO 44.56
  • WU 44.85
  • Support Level
  • AKRO $41.60
  • WU $9.63
  • Resistance Level
  • AKRO $46.47
  • WU $9.85
  • Average True Range (ATR)
  • AKRO 2.26
  • WU 0.27
  • MACD
  • AKRO 0.08
  • WU 0.00
  • Stochastic Oscillator
  • AKRO 21.84
  • WU 27.26

About AKRO Akero Therapeutics Inc.

Akero Therapeutics Inc is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious metabolic diseases with high unmet medical needs. Its focus is nonalcoholic steatohepatitis (MASH), or NASH, a disease without any approved therapies. The company's product candidate efruxifermin is an FGF21 analog with properties that have the potential to address the core processes underlying NASH pathogenesis.

About WU Western Union Company (The)

Western Union provides domestic and international money transfers through its global network of over 500,000 outside agents. The company handled almost 290 million transactions in 2024 and is the largest money transfer company in the world.

Share on Social Networks: